Lifecore Biomedical, Inc. Receives Notice From Nasdaq Regarding Delayed Annual Report
Portfolio Pulse from Happy Mohamed
Lifecore Biomedical, Inc. (NASDAQ:LFCR) has received a notice from Nasdaq for not complying with the Listing Rule 5250(c)(1) due to delayed filing of its Interim Report on Form 10-Q and Annual Report on Form 10-K. The company has submitted a plan to regain compliance and has until February 12, 2024, to file the reports. The notice does not immediately affect the company's listing or trading on the Nasdaq Global Select Market.
October 18, 2023 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lifecore Biomedical's delayed filing of its annual and interim reports has led to a notice from Nasdaq. The company has until February 12, 2024, to regain compliance, which does not immediately affect its listing or trading.
The notice from Nasdaq regarding the delayed filing of reports is a negative signal for Lifecore Biomedical. While it does not immediately affect the company's listing or trading, it may lead to uncertainty among investors, potentially impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100